H.C. Wainwright analyst Patrick Trucchio lowered the firm’s price target on Precision BioSciences to $17 from $20 and keeps a Buy rating on the shares post the Q3 results.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DTIL: